Risk Factors in Heart Disease: Therapeutic Interventions

Abstract

Get full access to this article

View all access options for this article.

References

Adluri

, Thirunavukkarasu

, Dunna

, Zhan

, Oriowo

, Takeda

, Sanchez

, Otani

, Maulik

, Fong

, Maulik

. Disruption of hypoxia-inducible transcription factor-prolyl hydroxylase domain-1 (PHD-1^-/-) attenuates ex vivo myocardial ischemia/reperfusion injury through hypoxia-inducible factor-1α transcription factor and its target genes in mice. Antioxid Redox Signal, 15:1789–1797. 2011.

Avlas

, Fallach

, Shainberg

, Porat

, Hochhauser

. Toll-like receptor 4 stimulation initiates an inflammatory response that decreases cardiomyocyte contractility. Antioxid Redox Signal, 15:1895–1909. 2011.

Baker

, Moulder

, Hopewell

. Radiation as a risk factor for cardiovascular disease. Antioxid Redox Signal, 15:1945–1956. 2011.

Brownlee

. The pathobiology of diabetic complications. Diabetes, 54:1615–1625. 2005.

Farag

YMK

, Gaballa

. Diabesity: an overview of a rising epidemic. Nephrol Dialysis Transpl, 26:28–35. 2011.

Gersh

, Sliwa

, Mayosi

, Yusuf

. Novel therapeutic concepts: the epidemic of cardiovascular disease in the developing world: global implications. Eur Heart J, 31:642–648. 2010.

Goldstein

, Scalia

, Ma

. Protective vascular and myocardial effects of adiponectin. Nat Clin Pract Cardiovasc Med, 6:27–35. 2008.

, Liu

, Kelley

, Kao

, Williams

, Li

. Toll-like receptors: new players in myocardial ischemia/reperfusion injury. Antioxid Redox Signal, 15:1875–1893. 2011.

Han

, Yoon

. Induced pluripotent stem cells: emerging techniques for nuclear reprogramming. Antioxid Redox Signal, 15:1799–1820. 2011.

10.

Kahn

, Buse

, Ferrannini

, Stern

. The metabolic syndrome: time for a critical appraisal. Diabetes Care, 28:2289–2304. 2005.

11.

Kang

. White adipose tissue as an endocrine organ. Autologous Fat Transfer. Shiffman

. Springer, 2010; 37–40.

12.

Karastergiou

, Mohamed-Ali

, Jahangiri

, Kaski

. Review: adiponectin for prediction of cardiovascular risk? Br J Diabetes Vasc Dis, 9:150. 2009.

13.

Lau

, Tao

, Wang

, Li

, Ma

. Systemic adiponectin malfunction as a risk factor for cardiovascular disease. Antioxid Redox Signal, 15:1863–1873. 2011.

14.

Levenson

, Skerrett

, Gaziano

. Reducing the global burden of cardiovascular disease: the role of risk factors. Prev Cardiol, 5:188–199. 2002.

15.

, Shin

, Ding

, van Dam

. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA, 302:179–188. 2009.

16.

Liu

, Ma

, Wang

, Xia

, Zhang

, Lian

, Luan

, Sun

, Yang

, Lau

, Wang

, Tao

. Advanced glycation end products accelerate ischemia/reperfusion injury through receptor of advanced end product/nitrative thioredoxin inactivation in cardiac microvascular endothelial cells. Antioxid Redox Signal, 15:1769–1778. 2011.

17.

Maiolino

, Cesari

, Sticchi

, Zanchetta

, Pedon

, Antezza

, Pessina

, Rossi

. Plasma adiponectin for prediction of cardiovascular events and mortality in high-risk patients. J Clin Endocrinol Metab, 93:3333–3340. 2008.

18.

Otani

. Oxidative stress as pathogenesis of cardiovascular risk associated with metabolic syndrome. Antioxid Redox Signal, 15:1911–1926. 2011.

19.

Rojas

, Mercadal

, Figueroa

, Morales

. Advanced glycation and ROS: a link between diabetes and heart failure. Curr Vasc Pharmacol, 6:44–51. 2008.

20.

Seidell

. Dietary fat and obesity: an epidemiologic perspective. Am J Clin Nutr 67(3, Suppl):546S–550S. 1998.

21.

Steed

, Tyagi

. Mechanisms of cardiovascular remodeling in hyperhomocysteinemia. Antioxid Redox Signal, 15:1927–1943. 2011.

22.

Turan

, Vassort

. Ryanodine receptor: a new therapeutic target to control diabetic cardiomyopathy. Antioxid Redox Signal, 15:1847–1861. 2011.

23.

, Ho

, Yet

. A central role of heme oxygenase-1 in cardiovascular protection. Antioxid Redox Signal, 15:1835–1846. 2011.

24.

, Sun

, Gao

, Wei

, Lau

, Zheng

, Wang

, Yuan

, Wang

, Tao

, Li

, Koch

, Ma

. Reduced cardioprotective action of adiponectin in high-fat diet–induced type II diabetic mice and its underlying mechanisms. Antioxid Redox Signal, 15:1779–1788. 2011.

25.

Zuba-Surma

, Wojakowski

, Ratajczak

, Dawn

. Very small embryonic-like stem cells: biology and therapeutic potential for heart repair. Antioxid Redox Signal, 15:1821–1834. 2011.

26.

Zucchi

, Ronca-Testoni

. The sarcoplasmic reticulum Ca2+ channel/ryanodine receptor: modulation by endogenous effectors, drugs and disease states. Pharmacol Rev, 49:1–51. 1997.